Viewing Study NCT00004104


Ignite Creation Date: 2025-12-24 @ 9:21 PM
Ignite Modification Date: 2025-12-31 @ 2:19 AM
Study NCT ID: NCT00004104
Status: COMPLETED
Last Update Posted: 2016-03-31
First Post: 1999-12-10
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: Vaccine Therapy Plus Interleukin-2 With or Without Interferon Alfa-2b in Treating Patients With Stage III Melanoma
Sponsor: NYU Langone Health
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Description Module Conditions Module Design Module Arms Interventions Module Eligibility Module Contacts Locations Module